Tatsis Ourania (CIK 1789815) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-23). Recent activity: Buy VRTX (8,251 shares), Sell VRTX (1,500 shares), Sell VRTX (1,627 shares), Sell VRTX (260 shares), Buy VRTX (5,789 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-23 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Buy | 8,251 | $0 |
| 2026-07-07 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 1,500 | $787,485 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 1,627 | $789,274 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 260 | $126,451 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Buy | 5,789 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 2,294 | $1.1M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 609 | $298,081 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 368 | $174,314 |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 3,804 | $1.9M |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 1,500 | $749,985 |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 2,140 | $1.0M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 466 | $214,560 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Buy | 7,866 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Buy | 3,883 | $0 |
| 2026-01-09 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 4,500 | $2.1M |
| 2025-12-05 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 4,500 | $2.0M |
| 2025-03-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 3,242 | $1.6M |
| 2025-03-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Reg. & Quality Off. | Sell | 4,058 | $2.0M |
Source: SEC Form 4 filings · as of 2026-07-23